EL PASO, TX--(Marketwired - Jan 18, 2017) - Premier Biomedical, Inc. (
The pain relief patches consist of a proprietary CBD hemp oil formulation with 20% more CBD, and a patch area 30% larger than competition, and are designed to provide up to 96 hours of continuous pain relief. The roll-on applicator contains 110 mg of our proprietary CBD formulation, 10% more CBD than the closest competitor.
Patients at the Center who sampled the products experienced "great pain relief," and refer to the products as "the pain killer."
William A. Hartman, President & CEO of PBPMS, stated, "We are very excited about the progress we have made in securing a distribution agreement, even before our own internet sales are available. Our plan has been to distribute samples of our products, and once the customer has tried them, they are convinced that our pain relief products are the best. We hope to make several announcements in the near future regarding additional distribution agreements." PBPMS will be selling their products via the internet beginning this month at www.painreliefmeds.com.
About Pain Relief & Wellness Strategy Center
The Pain Relief and Wellness Strategies Center is a world-class facility staffed by medical doctors, nurse practitioners, physical therapists, doctors of chiropractic, and a team of assistants offering state-of-the-art equipment, training and technology and has been providing cutting edge, non-drug, and non-surgical lasting pain relief and sound wellness strategies since 1989.
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
William A. Hartman
President and CEO
Premier Biomedical Inc.
(724) 633-7033
[email protected]
http://www.premierbiomedical.com/
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member